Opioids are psychoactive chemicals that bind to opioid receptors in the central nervous system, peripheral nervous system, and gastrointestinal tract. Opioid receptors are classified into μ, κ, and δ types. Opioids can function as agonists, partial agonists, or antagonists at these receptors. Opioids are classified based on their origin, such as natural, semisynthetic, or synthetic, and based on their strength and function, such as pure agonists, partial agonists, agonist-antagonists, or pure antagonists. The pharmacological actions of opioids include analgesia, respiratory depression, sedation, myosis, and decreased blood pressure through effects on the central nervous system, eyes,
Genetic variation in drug transportersDeepak Kumar
This document discusses various transporter proteins involved in drug transport. It describes two main superfamilies - ATP-binding cassette (ABC) transporters and Solute-carrier (SLC) transporters. ABC transporters such as P-glycoprotein, MRP1, and BCRP act as efflux pumps and influence the bioavailability and toxicity of various drugs like irinotecan. Genetic variants in these transporters affect individual responses to drugs. SLC transporters import substances and influence drug absorption and distribution. Variations in transporter expression across tissues and individuals impact drug pharmacokinetics and treatment outcomes.
Genetic polymorphisms can affect how individuals metabolize and respond to drugs. The document discusses how single nucleotide polymorphisms (SNPs) in genes encoding drug-metabolizing enzymes like the cytochrome P450 system can result in poor, intermediate, normal, extensive, or ultra-rapid metabolizers. This genetic variation impacts the metabolism of many drugs and can influence their effects as well as drug interactions. The cytochrome P450 2C19 enzyme, which is important in metabolizing diazepam, shows polymorphisms that lead to different drug responses and side effects between ethnic populations. Understanding these pharmacogenomic factors is important for optimizing drug therapy.
Classification of receptors family by vivek sharmaAnimatedWorld
Definition- Receptor are the biologic molecule to which drug bind and produces a measurable response.
So, enzyme and structural proteins can be considerd to be pharmacologic receptors.
Majorly receptor are of 4 types and the molecule or a drug interact to receptor to give response often called as ligand.
The type of receptor a ligand will bind is depend on the nature of ligand.
Hydrophilliic ligand binds to the receptor found on the cell surface.
Hydrophobic ligand can enter the cell membrane to intract the receptor present on inside the cells.
Classification of Receptors
A. Cell surface receptor
Ligand-gated Ion Channel
G Protein Coupled Receptor
Enzyme linked Receptor
B. Intracellular Receptor
Nuclear Receptor
Genetic variations in G protein-coupled receptors (GPCRs) can alter receptor function and cause diseases. Single nucleotide polymorphisms and other mutations have been linked to impaired or enhanced receptor signaling. For example, a mutation in the vasopressin V2 receptor causes nephrogenic diabetes insipidus by decreasing ligand binding and receptor expression. Similarly, mutations in chemokine receptors CCR5 and CCR2 impact HIV infection by altering receptor function or interaction with other coreceptors. Overall, GPCR polymorphisms are associated with diseases by changing ligand binding, receptor activation, trafficking, and coupling to downstream signaling pathways.
Genetic variation and its role in health pharmacologyDeepak Kumar
Genetic variation exists at different scales, from single nucleotide polymorphisms within individuals of a species to larger structural differences between species. Genetic variation arises through mutations, recombination, gene flow, genetic drift, and the interaction of these processes over time. The effective population size of a species influences how genetic variation is shaped by these evolutionary forces.
Opioids are psychoactive chemicals that bind to opioid receptors in the central nervous system, peripheral nervous system, and gastrointestinal tract. Opioid receptors are classified into μ, κ, and δ types. Opioids can function as agonists, partial agonists, or antagonists at these receptors. Opioids are classified based on their origin, such as natural, semisynthetic, or synthetic, and based on their strength and function, such as pure agonists, partial agonists, agonist-antagonists, or pure antagonists. The pharmacological actions of opioids include analgesia, respiratory depression, sedation, myosis, and decreased blood pressure through effects on the central nervous system, eyes,
Genetic variation in drug transportersDeepak Kumar
This document discusses various transporter proteins involved in drug transport. It describes two main superfamilies - ATP-binding cassette (ABC) transporters and Solute-carrier (SLC) transporters. ABC transporters such as P-glycoprotein, MRP1, and BCRP act as efflux pumps and influence the bioavailability and toxicity of various drugs like irinotecan. Genetic variants in these transporters affect individual responses to drugs. SLC transporters import substances and influence drug absorption and distribution. Variations in transporter expression across tissues and individuals impact drug pharmacokinetics and treatment outcomes.
Genetic polymorphisms can affect how individuals metabolize and respond to drugs. The document discusses how single nucleotide polymorphisms (SNPs) in genes encoding drug-metabolizing enzymes like the cytochrome P450 system can result in poor, intermediate, normal, extensive, or ultra-rapid metabolizers. This genetic variation impacts the metabolism of many drugs and can influence their effects as well as drug interactions. The cytochrome P450 2C19 enzyme, which is important in metabolizing diazepam, shows polymorphisms that lead to different drug responses and side effects between ethnic populations. Understanding these pharmacogenomic factors is important for optimizing drug therapy.
Classification of receptors family by vivek sharmaAnimatedWorld
Definition- Receptor are the biologic molecule to which drug bind and produces a measurable response.
So, enzyme and structural proteins can be considerd to be pharmacologic receptors.
Majorly receptor are of 4 types and the molecule or a drug interact to receptor to give response often called as ligand.
The type of receptor a ligand will bind is depend on the nature of ligand.
Hydrophilliic ligand binds to the receptor found on the cell surface.
Hydrophobic ligand can enter the cell membrane to intract the receptor present on inside the cells.
Classification of Receptors
A. Cell surface receptor
Ligand-gated Ion Channel
G Protein Coupled Receptor
Enzyme linked Receptor
B. Intracellular Receptor
Nuclear Receptor
Genetic variations in G protein-coupled receptors (GPCRs) can alter receptor function and cause diseases. Single nucleotide polymorphisms and other mutations have been linked to impaired or enhanced receptor signaling. For example, a mutation in the vasopressin V2 receptor causes nephrogenic diabetes insipidus by decreasing ligand binding and receptor expression. Similarly, mutations in chemokine receptors CCR5 and CCR2 impact HIV infection by altering receptor function or interaction with other coreceptors. Overall, GPCR polymorphisms are associated with diseases by changing ligand binding, receptor activation, trafficking, and coupling to downstream signaling pathways.
Genetic variation and its role in health pharmacologyDeepak Kumar
Genetic variation exists at different scales, from single nucleotide polymorphisms within individuals of a species to larger structural differences between species. Genetic variation arises through mutations, recombination, gene flow, genetic drift, and the interaction of these processes over time. The effective population size of a species influences how genetic variation is shaped by these evolutionary forces.
Chronotherapy is an approach to diabetes treatment that involves timing medication administration relative to a patient's circadian rhythms. Insulin secretion and sensitivity exhibit daily rhythmicity controlled by the circadian clock, and disrupting these rhythms can lead to impaired glucose metabolism and diabetes. Studies have found higher post-meal blood glucose levels in the evening compared to the morning, even after identical meals. Chronotherapy aims to optimize drug effects and safety by administering medications, like insulin and sensitizers, in line with a patient's circadian rhythms. This personalized timing of treatment can help improve glycemic control while reducing risks like hypoglycemia.
This document summarizes kinase receptors and nuclear receptors. Kinase receptors contain an extracellular ligand-binding domain connected by a transmembrane helix to an intracellular domain with kinase activity. They signal through phosphorylation cascades like MAPK. Nuclear receptors regulate gene transcription as ligand-activated transcription factors. They contain a ligand binding domain, DNA binding domain, and transcriptional regulation domain. Nuclear receptors form dimers and recruit cofactors to modify gene expression.
This document provides an overview of immunopharmacology. It begins by defining immunopharmacology and describing the immune system, including its components and mechanisms. The major components are the innate and adaptive immune responses. It then discusses various immunomodulators that can suppress the immune system like immunosuppressants or stimulate it like immunostimulants. Examples of therapies used in immunopharmacology are provided for immunosuppressants like cyclosporine and immunostimulants like levamisole. Recent advances in immunotherapy for conditions such as cancer are also summarized.
Definition
Classification and description of each class.
Description of individual receptor.
Forces affecting the drug receptor binding.
Binding of drug receptor affect drug action.
Agonist and antagonist.
Disease due to malfunctioning of receptors.
New drug design based on structure of receptors
Receptor as target for drug discovery.
Drug action not mediated by receptor.
Chronopharmacology is the science concerned with how the pharmacological effects of drugs vary over biological times and circadian rhythms. It takes into account that many physiological functions and disease states fluctuate over 24-hour cycles. Optimizing drug dosing according to circadian rhythms can increase efficacy and safety. Examples given include dosing asthma medications in the evening to prevent nighttime attacks, dosing blood pressure medications at night to prevent heart issues in the morning, and dosing ulcer medications at bedtime to reduce nighttime acid secretion. Recent advances include developing drug delivery systems to match circadian rhythms.
Chronopharmacology is the study of variations in drug effects over biological times and circadian rhythms. It considers how drugs interact with living systems depending on the time of day they are administered. Biological rhythms like circadian (24-hour), ultradian (<20 hours), and infradian (>28 hours) rhythms influence physiological functions and drug pharmacokinetics and pharmacodynamics. Chronotherapy aims to increase drug efficacy and safety by timing drug administration according to biological rhythms. It has applications in treating cancers, asthma, hypertension, strokes, and other conditions. Recent advances include circadian-aligned drug delivery systems and future approaches may integrate chronopharmacology with systems biology and nanomedicine.
Genetic variation in G protein coupled receptorsSachinGulia12
This document discusses genetic variation in G protein-coupled receptors (GPCRs). It notes that GPCRs are membrane proteins involved in cell signaling and the targets of many drugs. Genetic variations can influence drug efficacy and safety through several mechanisms: by altering the structure and function of GPCRs, their coupling to G proteins and signaling pathways, their binding pockets, and their spontaneous signaling. Specific examples of genetic variations in GPCRs that are associated with human diseases are also provided.
The document discusses the principles of pharmacodynamics, which is the study of how drugs act on the body. It describes how drugs interact with receptors like G-protein coupled receptors, ion channels, and transmembrane receptors to exert their effects. The mechanisms of drug action include receptor binding and activation of downstream signaling pathways like the cAMP pathway or phospholipase C pathway. The document provides examples of how different receptors and signaling pathways influence various physiological processes in the body.
OVERVIEW OF MODERN DRUG DISCOVERY PROCESSSweety gupta
The document provides an overview of the modern drug discovery process, which involves 5 main steps:
1) Target identification and validation to find the molecular structures involved in the disease.
2) Hit identification and validation to find small molecule leads that have the desired effect on the targets.
3) Moving from a hit to a lead by refining hits into more selective compounds.
4) Lead optimization to improve properties and address any deficiencies while maintaining desired effects.
5) Late lead optimization to further assess safety before clinical trials.
Modern drug discovery is an expensive process that can cost over $1 billion on average due to large investments required. Bioinformatics and genomic/proteomic technologies help accelerate the process and reduce
Histamine is an amine autocoid that is synthesized and stored in mast cells and basophils. It is released during allergic reactions and inflammation and acts both locally and systemically via four G protein-coupled receptors, H1-H4. The H1 receptor mediates smooth muscle contraction and increased capillary permeability. The H2 receptor increases gastric acid secretion and relaxes smooth muscles. Histamine plays an important role in allergic reactions, inflammation, gastric acid secretion, and neuronal signaling. It is involved in various physiological and pathological processes.
siRNA and miRNA both regulate gene expression, but through different mechanisms. siRNA targets specific gene sequences, while a single miRNA can regulate many genes. siRNA is found in plants, fungi, and insects but not mammals, which have other antiviral responses. miRNA are small non-coding RNAs around 22 nucleotides long that bind to mRNA to repress translation or promote degradation. They play important roles in development, physiology, and disease when their expression is dysregulated.
This document summarizes various preclinical screening methods used to evaluate potential anti-epileptic drugs. It describes several animal models of induced seizures including electroshock seizures, chemical-induced seizures using pentylenetetrazol or picrotoxin. It also discusses genetic models like the totterer mouse that is prone to spontaneous seizures. The key methods are maximal electroshock in mice/rats to test generalized tonic-clonic seizure protection and the pentylenetetrazol test in mice to assess anticonvulsant effects against petit mal-like seizures. These preclinical tests aim to predict potential efficacy of new compounds before clinical trials in humans.
PPT on Cellular and molecular mechanism of sex hormonesNaveen K L
- Sex hormones include androgens like testosterone and estrogens like estradiol. They are produced in the gonads and influence secondary sex characteristics.
- Testosterone promotes male traits and is produced in the testes, regulating functions like sex drive and muscle growth. It works through the androgen receptor in cells.
- Estrogens promote female traits and are produced in the ovaries, regulating the menstrual cycle and development of breasts and hair. The main types are estrone, estradiol, and estriol.
Genomics, proteomics, and bioinformatics are important fields that help advance drug development. Genomics studies entire genomes and can identify disease-associated genes. Proteomics identifies the proteins expressed in a sample and how they differ between healthy and diseased tissues. Bioinformatics uses computers to store and analyze biochemical and biological data, especially related to genomics. These fields help discover new drug targets, validate existing targets, select drug candidates, study mechanisms of action and toxicity. Integrating omics data from genomics to proteomics provides a more comprehensive understanding of biological systems compared to individual fields alone.
Non adrenergic non cholinergic transmission(nanc)Merlin Binu
Neurotransmitters other than Acetyl choline and NorAdrenaline of parasympathetic and sympathetic nervous system play important role in synaptic junction transmission. That neurotransmitters are called NANC.
The document summarizes recent advances in understanding and treating Alzheimer's disease. It discusses both non-modifiable and modifiable risk factors for the disease. The major signs and symptoms include progressive memory loss and cognitive decline. Alzheimer's is confirmed through neuronal plaques and tangles seen in the brain. Recent treatment strategies aim to reduce amyloid plaques through vaccines, antibodies, and inhibitors of beta- and gamma-secretase. Other approaches include tau phosphorylation inhibitors, therapies for mitochondrial dysfunction, and cholinesterase inhibitors. Animal models continue to be important for studying the human APP, ApoE, and presenilin genes involved in Alzheimer's pathology.
Combinatorial chemistry and high throughput screeningAnji Reddy
Combinatorial chemistry and high-throughput screening techniques allow for the rapid synthesis and testing of large libraries of compounds. Combinatorial chemistry uses solid and solution phase methods to efficiently produce thousands of compounds, while high-throughput screening employs automated instrumentation like microtiter plates to quickly assess large numbers of compounds through functional or non-functional assays. These approaches provide advantages for drug discovery by facilitating the identification of hit compounds for further optimization into drug leads.
This document discusses G protein-coupled receptors (GPCRs), which are the largest family of membrane receptors in the human genome. GPCRs have seven transmembrane domains and signal by interacting with G proteins. They regulate many important physiological processes and are involved in many diseases. The document outlines the structure and function of GPCRs and G proteins, including how GPCRs activate G proteins, the different classes of GPCRs, mechanisms of GPCR regulation like phosphorylation and desensitization, and the roles of GTPases in general.
This document provides information about a receptor pharmacology course taught by Professor Dr. Md. Shah Amran at the University of Dhaka. It was prepared by 5 students and contains contents on different types of receptors including ligand gated ion channels, G-protein coupled receptors, enzyme linked receptors, nuclear receptors, and a comparison of receptor types. Receptors are important macromolecules that bind drugs and mediate their effects in the body.
Chronotherapy is an approach to diabetes treatment that involves timing medication administration relative to a patient's circadian rhythms. Insulin secretion and sensitivity exhibit daily rhythmicity controlled by the circadian clock, and disrupting these rhythms can lead to impaired glucose metabolism and diabetes. Studies have found higher post-meal blood glucose levels in the evening compared to the morning, even after identical meals. Chronotherapy aims to optimize drug effects and safety by administering medications, like insulin and sensitizers, in line with a patient's circadian rhythms. This personalized timing of treatment can help improve glycemic control while reducing risks like hypoglycemia.
This document summarizes kinase receptors and nuclear receptors. Kinase receptors contain an extracellular ligand-binding domain connected by a transmembrane helix to an intracellular domain with kinase activity. They signal through phosphorylation cascades like MAPK. Nuclear receptors regulate gene transcription as ligand-activated transcription factors. They contain a ligand binding domain, DNA binding domain, and transcriptional regulation domain. Nuclear receptors form dimers and recruit cofactors to modify gene expression.
This document provides an overview of immunopharmacology. It begins by defining immunopharmacology and describing the immune system, including its components and mechanisms. The major components are the innate and adaptive immune responses. It then discusses various immunomodulators that can suppress the immune system like immunosuppressants or stimulate it like immunostimulants. Examples of therapies used in immunopharmacology are provided for immunosuppressants like cyclosporine and immunostimulants like levamisole. Recent advances in immunotherapy for conditions such as cancer are also summarized.
Definition
Classification and description of each class.
Description of individual receptor.
Forces affecting the drug receptor binding.
Binding of drug receptor affect drug action.
Agonist and antagonist.
Disease due to malfunctioning of receptors.
New drug design based on structure of receptors
Receptor as target for drug discovery.
Drug action not mediated by receptor.
Chronopharmacology is the science concerned with how the pharmacological effects of drugs vary over biological times and circadian rhythms. It takes into account that many physiological functions and disease states fluctuate over 24-hour cycles. Optimizing drug dosing according to circadian rhythms can increase efficacy and safety. Examples given include dosing asthma medications in the evening to prevent nighttime attacks, dosing blood pressure medications at night to prevent heart issues in the morning, and dosing ulcer medications at bedtime to reduce nighttime acid secretion. Recent advances include developing drug delivery systems to match circadian rhythms.
Chronopharmacology is the study of variations in drug effects over biological times and circadian rhythms. It considers how drugs interact with living systems depending on the time of day they are administered. Biological rhythms like circadian (24-hour), ultradian (<20 hours), and infradian (>28 hours) rhythms influence physiological functions and drug pharmacokinetics and pharmacodynamics. Chronotherapy aims to increase drug efficacy and safety by timing drug administration according to biological rhythms. It has applications in treating cancers, asthma, hypertension, strokes, and other conditions. Recent advances include circadian-aligned drug delivery systems and future approaches may integrate chronopharmacology with systems biology and nanomedicine.
Genetic variation in G protein coupled receptorsSachinGulia12
This document discusses genetic variation in G protein-coupled receptors (GPCRs). It notes that GPCRs are membrane proteins involved in cell signaling and the targets of many drugs. Genetic variations can influence drug efficacy and safety through several mechanisms: by altering the structure and function of GPCRs, their coupling to G proteins and signaling pathways, their binding pockets, and their spontaneous signaling. Specific examples of genetic variations in GPCRs that are associated with human diseases are also provided.
The document discusses the principles of pharmacodynamics, which is the study of how drugs act on the body. It describes how drugs interact with receptors like G-protein coupled receptors, ion channels, and transmembrane receptors to exert their effects. The mechanisms of drug action include receptor binding and activation of downstream signaling pathways like the cAMP pathway or phospholipase C pathway. The document provides examples of how different receptors and signaling pathways influence various physiological processes in the body.
OVERVIEW OF MODERN DRUG DISCOVERY PROCESSSweety gupta
The document provides an overview of the modern drug discovery process, which involves 5 main steps:
1) Target identification and validation to find the molecular structures involved in the disease.
2) Hit identification and validation to find small molecule leads that have the desired effect on the targets.
3) Moving from a hit to a lead by refining hits into more selective compounds.
4) Lead optimization to improve properties and address any deficiencies while maintaining desired effects.
5) Late lead optimization to further assess safety before clinical trials.
Modern drug discovery is an expensive process that can cost over $1 billion on average due to large investments required. Bioinformatics and genomic/proteomic technologies help accelerate the process and reduce
Histamine is an amine autocoid that is synthesized and stored in mast cells and basophils. It is released during allergic reactions and inflammation and acts both locally and systemically via four G protein-coupled receptors, H1-H4. The H1 receptor mediates smooth muscle contraction and increased capillary permeability. The H2 receptor increases gastric acid secretion and relaxes smooth muscles. Histamine plays an important role in allergic reactions, inflammation, gastric acid secretion, and neuronal signaling. It is involved in various physiological and pathological processes.
siRNA and miRNA both regulate gene expression, but through different mechanisms. siRNA targets specific gene sequences, while a single miRNA can regulate many genes. siRNA is found in plants, fungi, and insects but not mammals, which have other antiviral responses. miRNA are small non-coding RNAs around 22 nucleotides long that bind to mRNA to repress translation or promote degradation. They play important roles in development, physiology, and disease when their expression is dysregulated.
This document summarizes various preclinical screening methods used to evaluate potential anti-epileptic drugs. It describes several animal models of induced seizures including electroshock seizures, chemical-induced seizures using pentylenetetrazol or picrotoxin. It also discusses genetic models like the totterer mouse that is prone to spontaneous seizures. The key methods are maximal electroshock in mice/rats to test generalized tonic-clonic seizure protection and the pentylenetetrazol test in mice to assess anticonvulsant effects against petit mal-like seizures. These preclinical tests aim to predict potential efficacy of new compounds before clinical trials in humans.
PPT on Cellular and molecular mechanism of sex hormonesNaveen K L
- Sex hormones include androgens like testosterone and estrogens like estradiol. They are produced in the gonads and influence secondary sex characteristics.
- Testosterone promotes male traits and is produced in the testes, regulating functions like sex drive and muscle growth. It works through the androgen receptor in cells.
- Estrogens promote female traits and are produced in the ovaries, regulating the menstrual cycle and development of breasts and hair. The main types are estrone, estradiol, and estriol.
Genomics, proteomics, and bioinformatics are important fields that help advance drug development. Genomics studies entire genomes and can identify disease-associated genes. Proteomics identifies the proteins expressed in a sample and how they differ between healthy and diseased tissues. Bioinformatics uses computers to store and analyze biochemical and biological data, especially related to genomics. These fields help discover new drug targets, validate existing targets, select drug candidates, study mechanisms of action and toxicity. Integrating omics data from genomics to proteomics provides a more comprehensive understanding of biological systems compared to individual fields alone.
Non adrenergic non cholinergic transmission(nanc)Merlin Binu
Neurotransmitters other than Acetyl choline and NorAdrenaline of parasympathetic and sympathetic nervous system play important role in synaptic junction transmission. That neurotransmitters are called NANC.
The document summarizes recent advances in understanding and treating Alzheimer's disease. It discusses both non-modifiable and modifiable risk factors for the disease. The major signs and symptoms include progressive memory loss and cognitive decline. Alzheimer's is confirmed through neuronal plaques and tangles seen in the brain. Recent treatment strategies aim to reduce amyloid plaques through vaccines, antibodies, and inhibitors of beta- and gamma-secretase. Other approaches include tau phosphorylation inhibitors, therapies for mitochondrial dysfunction, and cholinesterase inhibitors. Animal models continue to be important for studying the human APP, ApoE, and presenilin genes involved in Alzheimer's pathology.
Combinatorial chemistry and high throughput screeningAnji Reddy
Combinatorial chemistry and high-throughput screening techniques allow for the rapid synthesis and testing of large libraries of compounds. Combinatorial chemistry uses solid and solution phase methods to efficiently produce thousands of compounds, while high-throughput screening employs automated instrumentation like microtiter plates to quickly assess large numbers of compounds through functional or non-functional assays. These approaches provide advantages for drug discovery by facilitating the identification of hit compounds for further optimization into drug leads.
This document discusses G protein-coupled receptors (GPCRs), which are the largest family of membrane receptors in the human genome. GPCRs have seven transmembrane domains and signal by interacting with G proteins. They regulate many important physiological processes and are involved in many diseases. The document outlines the structure and function of GPCRs and G proteins, including how GPCRs activate G proteins, the different classes of GPCRs, mechanisms of GPCR regulation like phosphorylation and desensitization, and the roles of GTPases in general.
This document provides information about a receptor pharmacology course taught by Professor Dr. Md. Shah Amran at the University of Dhaka. It was prepared by 5 students and contains contents on different types of receptors including ligand gated ion channels, G-protein coupled receptors, enzyme linked receptors, nuclear receptors, and a comparison of receptor types. Receptors are important macromolecules that bind drugs and mediate their effects in the body.
This document provides information about a receptor pharmacology course taught by Professor Dr. Md. Shah Amran at the University of Dhaka. It was prepared by 5 students and contains an introduction to receptors, classifications of different receptor types including ligand gated ion channels, G-protein coupled receptors, enzyme linked receptors, and nuclear receptors. It also discusses receptor-drug interactions, affinity, intrinsic activity, and mechanisms of cell surface and intracellular receptors.
Basic concepts of G – protein coupled receptor.pptxssuser1c7442
G-protein coupled receptors (GPCRs) are transmembrane receptors that activate intracellular signaling pathways in response to extracellular stimuli. They have seven transmembrane domains and transmit signals by coupling to heterotrimeric G proteins on the intracellular side of the cell membrane. When an agonist binds to a GPCR, it causes a conformational change that activates the G protein, which then dissociates into α and βγ subunits to regulate downstream effector molecules like adenylyl cyclase. The activated G protein subunits stimulate intracellular signaling cascades until the G protein's GTP is hydrolyzed, terminating the signal. GPCRs make up a large protein family and are the targets of many drugs.
G-protein coupled receptors (GPCRs) are integral membrane proteins that detect molecules outside the cell and activate internal signal transduction pathways. They have seven transmembrane domains and couple with G proteins. Ligand binding causes a conformational change in the receptor that activates the G protein, starting signaling cascades. The main signaling pathways are cAMP, phosphatidylinositol, and Rho/ROCK. GPCRs mediate many physiological processes like vision, smell, immune response, and homeostasis. They are also involved in many diseases and are drug targets.
GPCRs are the most dynamic and most abundant all the receptors. The G protein-coupled receptor (GPCR) superfamily comprises the largest and most diverse group of proteins in mammals. GPCRs are responsible for every aspect of human biology from vision, taste, sense of smell, sympathetic and parasympathetic nervous functions, metabolism, and immune regulation to reproduction. GPCRs interact with a number of ligands ranging from photons, ions, amino acids, odorants, pheromones, eicosanoids, neurotransmitters, peptides, proteins, and hormones.
Nevertheless, for the majority of GPCRs, the identity of their natural ligands is still unknown, hence remain orphan receptors.
The simple dogma that underpins much of our current understanding of GPCRs, namely,
one GPCR gene− one GPCR protein− one functional GPCR− one G protein −one response
is showing distinct signs of wear.
Genetic variations in G protein-coupled receptors (GPCRs) can lead to changes in receptor structure and function resulting in disease. GPCRs interact with G proteins and undergo conformational changes upon ligand binding to signal inside cells. Single nucleotide polymorphisms account for most genetic variations and can occur in transmembrane domains, extracellular/intracellular loops, or terminal tails. Variations may affect ligand binding pockets, G protein coupling, or cause constitutive receptor activation. This can result in impaired or enhanced receptor signaling causing diseases like nephrogenic diabetes insipidus or bleeding disorders. Several examples of variants in receptors for hormones, chemokines, biogenic amines are described that link genetic changes to associated pathological phenotypes.
This document outlines the course for an introduction to medicinal chemistry. It covers 13 lectures over drug targets like proteins, enzymes, and receptors. Specific topics include ion channels, G-protein coupled receptors, molecular interactions, drug development, screening methods, and specific drug classes like antivirals and anti-cancer drugs. Each lecture is led by either Sophie R. Beeren or Luca Laraia and corresponds to chapters in the textbook.
G protein-coupled receptors (GPCRs) are a large family of transmembrane receptors that sense molecules outside the cell and activate intracellular signal transduction pathways. They have seven transmembrane domains and transmit signals by coupling to heterotrimeric G proteins on the inner cell surface. When an agonist binds to a GPCR, it causes a conformational change that activates the G protein, starting intracellular signaling cascades through second messengers like cAMP or IP3. Approximately half of all drugs target GPCRs, making them an important drug discovery area.
G protein-coupled receptors (GPCRs) are a large family of transmembrane receptors that sense molecules outside the cell and activate intracellular signal transduction pathways. They have seven transmembrane domains and transmit signals by coupling to heterotrimeric G proteins on the inner cell surface. When an agonist binds to a GPCR, it causes a conformational change that activates the G protein, starting intracellular signaling cascades through second messengers like cAMP or IP3. Approximately half of all drugs target GPCRs, making them an important drug discovery area.
G-protein coupled receptors (GPCRs) are the largest family of membrane receptors that sense molecules outside the cell and activate intracellular signal transduction pathways. They have seven transmembrane domains and work by coupling to intracellular G proteins. When an agonist binds to a GPCR, it causes a conformational change that activates the G protein, starting intracellular signaling cascades like the cAMP or PLC pathways. These pathways control many cellular functions and make GPCRs the targets of about half of all drugs.
genetic variation in gpcr and its disease due to variationNittalVekaria
1. GPCRs are the largest family of membrane receptors and are important drug targets. They signal through heterotrimeric G proteins and can exist in multiple conformations to trigger distinct pathways.
2. Genetic variations in GPCRs, such as single nucleotide polymorphisms, contribute to inter-individual differences in disease susceptibility and drug responses. Variations can impact receptor structure and function, G protein coupling, and ligand binding pockets.
3. Some GPCR variations are associated with diseases. For example, mutations in vasopressin V2 receptors cause nephrogenic diabetes insipidus by producing non-functional receptors, while mutations in chemokine receptors protect against HIV infection.
G-proteins are molecular switches that regulate various cellular activities. They exist in two classes: monomeric small GTPases and heterotrimeric complexes consisting of α, β, and γ subunits. G-protein coupled receptors (GPCRs) have seven transmembrane domains and interact with G-proteins via intracellular loops to transmit extracellular signals within the cell. Genetic variations in GPCRs can affect receptor functions like ligand binding and G-protein coupling, potentially causing diseases. Many single nucleotide polymorphisms and mutations have been linked to impaired or enhanced receptor signaling and diseases ranging from bleeding disorders to asthma, obesity, and immune deficiencies.
This document discusses different types of receptors and how they transmit signals. It describes two main domains of receptors - a recognition domain that binds hormones and a coupling domain that generates an intracellular signal. It also discusses three types of cell surface receptors - ion channel receptors, transmembrane receptors, and receptors that are kinases or bind kinases. Steroid hormones can directly activate genes by diffusing into the cell and binding intracellular receptors, which then bind DNA and activate transcription.
This document discusses signal transduction and G protein-coupled receptors (GPCRs). It begins by defining signal transduction as the process of converting extracellular signals into intracellular responses using signaling molecules, receptors, signal transduction proteins, and second messengers. It then focuses on GPCRs, describing their 7 transmembrane structure and how they activate intracellular signaling pathways by interacting with trimeric G proteins in response to ligand binding. Specifically, ligand binding causes a GPCR conformational change that activates the G protein, which then activates downstream effectors like ion channels or enzymes to elicit a cellular response.
This document discusses signal transduction and G protein-coupled receptors (GPCRs). It begins with an overview of general principles of signal transduction, including extracellular signaling molecules, cell surface receptors, intracellular signal transduction proteins, and cellular responses. It then focuses on GPCRs, describing their structure, mechanism of activating trimeric G proteins, and examples of GPCRs that regulate various downstream effectors like ion channels and adenylyl cyclase. Specific GPCR pathways discussed include those for epinephrine, muscarinic acetylcholine, and rhodopsin in vision.
This document discusses signal transduction and G protein-coupled receptors (GPCRs). It begins with an overview of general principles of signal transduction, including extracellular signaling molecules, cell surface receptors, intracellular signal transduction proteins, and cellular responses. It then focuses on GPCRs, describing their structure, mechanism of activating G proteins, and examples of specific GPCRs such as rhodopsin and epinephrine receptors. Rhodopsin signaling in vision and epinephrine signaling pathways are discussed in detail.
This document discusses signal transduction and G protein-coupled receptors (GPCRs). It begins by defining signal transduction as the process of converting extracellular signals into intracellular responses using signaling molecules, receptors, signal transduction proteins, and second messengers. It then focuses on GPCRs, describing their 7 transmembrane structure and how they activate intracellular signaling pathways by interacting with trimeric G proteins in response to ligand binding. Specifically, ligand binding causes a GPCR conformational change that activates the G protein, which then activates downstream effectors like ion channels or enzymes to elicit a cellular response.
This document provides an overview of cell signaling pathways. It discusses several types of signaling including endocrine, paracrine, and autocrine signaling. It also describes different classes of receptors including G protein-coupled receptors and receptor tyrosine kinases. Several conserved signaling proteins and pathways are outlined, including heterotrimeric G proteins, kinases, adaptor proteins, and second messengers such as cAMP, IP3, DAG, and calcium. Specific pathways involving G protein-coupled receptors and their associated G proteins, second messengers, and downstream effects are examined in detail.
Similar to Molecular pharmacology of cell signling (20)
This document summarizes drugs that act on the central nervous system, focusing on anticonvulsant drugs. It discusses the mechanisms of action and therapeutic uses of various anticonvulsant drugs including barbiturates, benzodiazepines, valproic acid, gabapentin and others. It also outlines some of the adverse effects associated with these drugs. The document provides information on how these drugs stabilize neuronal membranes, activate GABA receptors, and alter ion channel permeability to raise the seizure threshold.
This curriculum vitae summarizes the qualifications of Mohanad A. Al-Bayati, an Assistant Professor of Physiology and Pharmacology at the University of Baghdad. It outlines his education, including a BVM&S, MSc in Physiology, and PhD in Pharmacology and Toxicology. It also lists his academic positions, teaching experience, research interests in reproductive physiology and the nitric oxide system, publications, and thesis supervision of 64 students.
This document discusses pharmacogenetics, which refers to how genetic differences can affect individual responses to drugs in terms of therapy and adverse effects. It provides examples of genetic polymorphisms that can influence drug metabolizing enzymes and transporters, affecting how drugs are absorbed, metabolized, or interact with receptors. Understanding these genetic factors helps explain variability in drug responses between individuals and can help physicians optimize treatment plans.
This document appears to be about endocrinology and hormones. It includes sections about hormonal homeostasis, hormonal classes, feedback control of the hypothalamic-pituitary axis, cell receptors and communication, and hypothalamic-pituitary hormones. The document is authored by Mohanad AlBayati and seems intended to provide information on advance pharmacology topics related to hormones and endocrinology.
This document provides biographical information about Mohanad AlBayati and summarizes key discoveries related to nitric oxide (NO) and endothelium-derived vasodilators. It discusses:
1) The 1977-1986 discoveries by Furchgott, Murad, and Ignarro that acetylcholine causes relaxation via endothelium-derived NO and that NO is identical to endothelium-derived relaxing factor (EDRF), earning them the 1998 Nobel Prize.
2) The endothelium releases vasodilators like NO and prostacyclin and vasoconstrictors like endothelin-1 and reactive oxygen species to regulate vascular tone.
3) NO activates guanylate cyclase, increasing cGMP and
This document provides contact information for Mohanad AlBayati and discusses the hypothalamic-pituitary hormones and how drugs can interfere with them. It describes the anatomy of the hypothalamus and pituitary gland, including the third ventricle, optic chiasm, infundibular stalk, anterior lobe, posterior lobe, and intermediate lobe. It also discusses null cells, endocrine-secreting cells, proopiomelanocortin, and how growth hormone can be interfered with by drugs. The document focuses on the interactions between hormones and pharmacology.
The document discusses therapeutic hypothermia and the body's mechanisms for temperature regulation, including external heat transfer and the hypothalamus controlling processes like skin blood flow and sweating. It also examines the possible mechanisms underlying the beneficial and risk factors of induced hypothermia, and covers topics like excitotoxicity which is related to excessive activation of glutamate receptors in the central nervous system.
This document contains information about Mohanad AlBayati, an Assistant Professor of Pharmacology and Toxicology at the University of Baghdad. It also defines key terms related to method precision including: relative standard deviation, inter-assay precision, intermediate precision, reproducibility, and accuracy. Accuracy is described as comparing a substance analyzed by a method to a reference standard analyzed by the same procedure.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Molecular pharmacology of cell signling
1. Molecular Pharmacology
of
Cell Signaling
Mohanad AlBayati
Mohanad AbdulSattar Ali Al-Bayati, BVM&S, MSc. Physiol., PhD.
Assistant Professor of Pharmacology and Toxicology
Department of Physiology and Pharmacology
College of Veterinary Medicine
University of Baghdad
Al Ameria, Baghdad
Phone: 0964 7802120391
E. Mail: aumnmumu@covm.uobaghdad.edu.iq
aumnmumu@yahoo.com
2. Previous soundness of drug cell
signal
• What is cell signaling?
• Signal transduction
• Receptors
• Types
• Functions
• Steps for signaling
7. Receptors
Receptors are the sites at which biomolecules such as
hormones, neurotransmitters and the molecules responsible
for taste and odour are recognised.
A drug that binds to a receptor can either:
• Trigger the same events as the native ligand - an agonist.
Or
• Stop the binding of the native agent without eliciting a
response - an antagonist.
There are four ‘superfamilies’ of receptors.
8. . These have 4 or 5 membrane-spanning helical subunits.
Their N- and C-terminii are found in the extracellular fluid. This family
includes ion channels.
. These have 7 helical transmembrane regions. Their N-
terminal is extracellular and the C-terminal in intracellular. This family
is coupled to the action of G-proteins: They are known as the G-
protein coupled receptors.
. These are tyrosine kinase-linked receptors with a single
transmembrane helix. The insulin and growth factor receptors fall
within this family.
. These receptors are found in the cell nucleus and are
transcription factors. They have looped regions held together by a
group of four cysteine residues coordinating to a zinc ion. These motifs
are called zinc fingers. The receptor ligands include steroids and
thyroid hormones.
Receptors
9. Today soundness of drug cell
signal
What is G protein coupled receptor
Regulation
What is G protein
Regulation
Mode of action
10.
11.
12. G-protein-Coupled Receptors may dimerize or form
oligomeric complexes within the membrane.
Ligand binding may promote oligomerization, which may
in turn affect activity of the receptor.
Various GPCR-interacting proteins (GIPs) modulate
receptor function. Effects of GIPs may include:
altered ligand affinity
receptor dimerization or oligomerization
control of receptor localization, including transfer to
or removal from the plasma membrane
promoting close association with other signal proteins
47. The G Protein-Coupled Receptor
(GPCR) Superfamily
• Largest known receptor family –
Constitutes > 1% of the genome.
• Comprises receptors for a diverse array of molecules:
neurotransmitters, odorants, lipids, neuropeptides,
large glycoprotein hormones.
• Odorant receptor family alone contains hundreds of
genes.
• Mammalian GPCRs: nearly 300 different kinds –
grouped into 3 main subfamilies:
48. • Each GPCR family contains some orphan receptors,
which have been identified as members of the GPCR
superfamily by homology cloning but whose
activating ligand is unknown.
• But high throughput screening has recently added to
the advances in being able to identify the ligand.
49. • GPCRs Interact guanine nucleotide-binding
proteins (aka G-proteins)
• Largest family of membrane proteins in the
human genome
• Eukaryotic trans membrane receptors
• Seven helices spanning the membrane
50. Roles:
- Light and smell processing
- Behavior and mood
- Immune response
- Autonomic nervous system
transmission
- Blood pressure
- Heart rate
- Digestive processes
- CRITICAL FACTOR IN MANY DISEASES!
51. Five different classes (based on sequence and
function):
- Class A: Rhodopsin-like receptors
- Class B: Secretin receptor family
- Class C: Metabotropic
glutamate/pheromone
- Class D: Fungal pheromone receptors
- Class E: Cyclyic AMP receptors
52. Almost all Receptors Comprise a
Number of Subtypes
• Dopamine receptors - 5 subtypes
• 5-HT receptors – 13 subtypes
• mGlu receptors - 8 subtypes
• Acetylcholine receptors – 5 subtypes
• Identified by their pharmacological and functional
characteristics, rather than by strict sequence
homology:
- Some receptors for the same ligand show
remarkably little homology (e.g., histamine H3
and H4 have the lowest recorded homology (~ 20
%) to other histamine receptors H1 and H2).
53.
54. Regulation of G protein-coupled
receptor function
Desensitization/resensitization– a decrease in responsiveness
during continuous drug application or a right-shift in a drug
dose-response curve.
After removal of the drug, receptor activity recovers, although
the speed and extent of this resensitization can depend on
the duration of agonist activation.
Rapid desensitization (sec-min) results from receptor phos,
arrestin binding, and receptor internalization.
Long-term desensitization (down-regulation) involve changes in
receptor and/or G protein levels, and their mRNA stability and
expression.
Long-term changes in [GPCR]s and [accessory proteins]s known
to be induced by chronic drug treatment and involved in
several pathologies.
55. Phosphorylation
2nd messenger kinase
G protein receptor kinase (GRK)
Arrestin
β-arrestin binding to phosphorylated GPCR is
required to decrease GTPase activity prior to
desensitization.
Receptor trafficking, internalization, and
recycling (covered earlier; see Protein
trafficking and LGIC slides).
56. Mechanisms of long-term down regulation
Long-term (> 1 hr) treatment with agonist induces the loss of total
cellular receptor number in addition to the decr in surface receptor
number.
e.g., antidepressants (e.g., fluoxetine) incr [5HT]synapse decr 5HT
receptor density.
Receptor endocytosis: C-terminal domain determines whether they
enter the recycle pathway or the lysosomal pathway:
- 2 distinct motifs:
1. PDZ-domain interats with NHERF in a phos-dependent manner.
2. A short sequence that interacts with NSF (N-ethylmaleimide
sensitive factor).
Arrestin has also been shown to be important for recycling:
e.g., V2 vasopressin receptor, which continues to bind arrestin while in
endosomes, does not recycle back to plasma membrane.
57. D D D D
α
α
β
α γ
(1) Agonist binding
and G protein
activation
(2) Phosphorylation
P P
(3) Arrestin
binding
Arrestin
P P
Arrestin
P P
Clathrin(4) Clustering in
clathrin-coated
pits
(5) EndocytosisEndosomes
Arrestin
P P
D
(7) Recycling
(6) Dissociation of agonist:
• Dephosphorylation
• Sorting between cycling
and lysosomal pathways
(8) Traffic to
lysosomes
Lysosomes
Mechanisms of Receptor Regulation
60. What are G-proteins?
• G proteins bind GTP: guanosine triphosphate. Control and amplify
intracellular signaling pathways
Exist in two states 1) bound GTP: active
2) bound GDP: inactive
Fig. 15.1
Examples of GTPase proteins
Ras, Cdc-42
(hormone, GF, drug)
61. 1994 Nobel Prize in Medicine, Alfred Gilman and
Martin Rodbell, for their „discovery of G-Proteins
and the role of these proteins in signal
transduction in cells.“
63. G-Protein families
• Heterotrimeric G-Proteins (Transducin, Gi, Gq …), in
7-TM receptor signalling
• Initiation, elongation, termination factors in protein
synthesis (IF1, EF-Tu, EF-TS)
• Signal recognition particle (SRP) and its receptor,
translocation of nascent polypeptide chains in the ER
• Ras-like GTPases (Ras, Rap, Rho, Ran, Rab, Arf, Arl,
Sar), molecular switches in signal transduction
• Dynamin superfamily of GTPases, remodelling of
membranes
+ 60 further distinct families
Leipe et al., JMB (2002)
64. GTPases and disease.
• Damage to these small GTPase switches can have
catastrophic consequences for the cell and the
organism.
• Several small GTPases of the Rac/Rho subfamily are
direct targets for clostridial cytotoxins.
• Further, Ras proteins are mutated to a constitutively-
active (GTP-bound) form in approximately 20% of
human cancers.
65. G-proteins are tightly regulated
3 types of accessory proteins that modulate cycling
of G-proteins between GTP/GDP
1. GAPs: GTPase-activating proteins. Stimulate GTP hydrolysis.
Inactivate G-protein. Example of a GAP: PLC.
2. GEFs: Guanine nucleotide-exchange factors: G-protein-coupled
receptors (GPCR). Stimulate dissociation of GDP (inactive) from
G-protein so GTP can bind (active).
3. GDIs: Guanine nucleotide-dissociation inhibitors. Inhibit release
of bound GDP (maintain G-protein in inactive state).
66. The heterotrimeric G proteins transmit signals
from a variety of cell surface receptors to enzymes
and channels
• Stimulated by receptors
• Act on effectors
• Regulated by nucleotide
exchange and hydrolysis
67. The signal is usually passed from a 7-helix receptor to an
intracellular G-protein.
Seven-helix receptors are thus called GPCR, or G-
Protein-Coupled Receptors.
Approx. 800 different GPCRs are encoded in the human
genome.
68. G-proteins are heterotrimeric, with 3 subunits , , .
A G-protein that activates cyclic-AMP formation within
a cell is called a stimulatory G-protein, designated Gs
with alpha subunit Gs.
Gs is activated, e.g., by receptors for the hormones
epinephrine and glucagon.
The -adrenergic receptor is the GPCR for
epinephrine.
69. These domains include residues adjacent to the terminal
phosphate of GTP and/or the Mg++ associated with the
two terminal phosphates.
Inhibitory G
GTPS
PDB 1GIAStructure of G proteins:
The nucleotide binding site
in G consists of loops that
extend out from the edge of
a 6-stranded -sheet.
Three switch domains have
been identified, that change
position when GTP
substitutes for GDP on G.
70. GTP hydrolysis occurs by nucleophilic attack of a water
molecule on the terminal phosphate of GTP.
Switch domain II of G includes a conserved glutamine
residue that helps to position the attacking water
molecule adjacent to GTP at the active site.
O
OHOH
HH
H
CH2
H
OPOPOP
O
O
O
O
O O
O
NH2
NH
NN
N
O
H O
H
GTP hydrolysis
71. The subunit of the heterotrimeric G Protein has a
-propeller structure, formed from multiple repeats of a
sequence called the WD-repeat.
The -propeller provides a stable structural support for
residues that bind G.
It is a common structural motif for protein domains
involved in protein-protein interaction.
G - side view of -propeller
PDB 1GP2
G – face view of -propeller
PDB 1GP2
72. The family of heterotrimeric G proteins includes also:
transducin, involved in sensing of light in the retina.
G-proteins involved in odorant sensing in olfactory
neurons.
There is a larger family of small GTP-binding switch
proteins, related to G.
73. Small GTP-binding proteins include (roles indicated):
initiation & elongation factors (protein synthesis).
Ras (growth factor signal cascades).
Rab (vesicle targeting and fusion).
ARF (forming vesicle coatomer coats).
Ran (transport of proteins into & out of the nucleus).
Rho (regulation of actin cytoskeleton)
All GTP-binding proteins differ in conformation
depending on whether GDP or GTP is present at their
nucleotide binding site.
Generally, GTP binding induces the active state.
74. A GAP may provide an essential active site residue, while
promoting the correct positioning of the glutamine
residue of the switch II domain.
Frequently a (+) charged arginine residue of a GAP
inserts into the active site and helps to stabilize the
transition state by interacting with () charged O atoms
of the terminal phosphate of GTP during hydrolysis.
Most GTP-binding
proteins depend on
helper proteins:
GAPs, GTPase Activating
Proteins, promote GTP
hydrolysis.
protein-GTP (active)
GDP
GEF GAP
GTP Pi
protein-GDP (inactive)
75. G of a heterotrimeric G protein has innate capability
for GTP hydrolysis.
It has the essential arginine residue normally provided
by a GAP for small GTP-binding proteins.
However, RGS proteins, which are negative regulators
of G protein signaling, stimulate GTP hydrolysis by G.
protein-GTP (active)
GDP
GEF GAP
GTP Pi
protein-GDP (inactive)
76. An activated receptor (GPCR) normally serves as GEF
for a heterotrimeric G-protein.
Alternatively, AGS (Activator of G-protein Signaling)
proteins may activate some heterotrimeric G-proteins,
independent of a receptor.
Some AGS proteins have GEF activity.
protein-GTP (active)
GDP
GEF GAP
GTP Pi
protein-GDP (inactive)
GEFs, Guanine Nucleotide
Exchange Factors, promote
GDP/GTP exchange.
77. & subunits have covalently attached lipid anchors that
bind a G-protein to the plasma membrane cytosolic surface.
Adenylate Cyclase (AC) is a transmembrane protein, with
cytosolic domains forming the catalytic site.
AC
hormone
signal
outside
GPCR plasma
membrane
GTP GDP ATP cAMP + PPi
cytosol
GDP GTP
The subunit of
a G-protein (G)
binds GTP, & can
hydrolyze it to
GDP + Pi.
78.
79. The sequence of events by which a hormone activates
cAMP signaling:
1. Initially G has bound GDP, and ,, & subunits
are complexed together.
G,, the complex of & subunits, inhibits G.
AC
hormone
signal
outside
GPCR plasma
membrane
GTP GDP ATP cAMP + PPi
cytosol
GDP GTP
80. 2. Hormone binding, usually to an extracellular domain
of a 7-helix receptor (GPCR), causes a conformational
change in the receptor that is transmitted to a G-protein
on the cytosolic side of the membrane.
The nucleotide-binding site on G becomes more accessible
to the cytosol, where [GTP] > [GDP].
G releases GDP & binds GTP (GDP-GTP exchange).
AC
hormone
signal
outside
GPCR plasma
membrane
GTP GDP ATP cAMP + PPi
cytosol
GDP GTP
81. 3. Substitution of GTP for GDP causes another
conformational change in G.
G-GTP dissociates from the inhibitory complex & can
now bind to and activate Adenylate Cyclase.
AC
hormone
signal
outside
GPCR plasma
membrane
GTP GDP ATP cAMP + PPi
cytosol
GDP GTP
88. Regulation at the G protein level
Regulator of G protein signaling (RGS = GAPs = GTPase
activating proteins) family of proteins (> 20
members) regulate the rate of GTP hydrolysis in the
Gα subunit.
Can also attenuate G protein actions that are mediated
by βγ subunits, because they can alter the number of
βγ available by enhancing the affinity of Gα subunits
for the βγ after GTP hydrolysis incr rate of
reformation of the heterotimer.
89. Regulation at the G protein level (cont’d)
RGS proteins also important in regulating the temporal
characteristics of G protein actions.
E.g., RGS proteins accelerate the decay of agonist-
induced activation of GIRK (G protein regulated
inward rectifying K channels).
E.g., RGS proteins accelerate desensitization of
adrenergic receptor-induced N-type Ca2+ channel
currents.
90. • ADH - Promotes water retention by
the kidneys (V2 Cells of Posterior Pituitary)
• GHRH - Stimulates the synthesis and release of
GH (Somatotroph Cells of Anterior Pituitary)
• GHIH - Inhibits the synthesis and release of GH
(Somatotroph Cells of Anterior Pituitary)
• CRH - Stimulates the synthesis and release of
ACTH (Anterior Pituitary)
91. • ACTH - Stimulates the synthesis and release of
Cortisol (zona fasiculata of adrenal cortex in
kidneys)
• TSH - Stimulates the synthesis and release of a
majority of T4 (Thyroid Gland)
• LH - Stimulates follicular maturation and
ovulation in women; Stimulates testosterone
production and spermatogenesis in men
92. • FSH - Stimulates follicular development in women;
Stimulates spermatogenesis in men
• PTH - Increases blood calcium levels (PTH1 Receptor:
Kidneys and Bone; PTH2 Receptor: Central Nervous
system, Bones, Kidneys, Brain)
• Calcitonin - Decreases blood calcium levels (Calcitonin
Receptor: Intestines, Bones, Kidneys, Brain)
• Glucagon - Stimulates glycogen breakdown (liver)
• hCG - Promotes cellular differentiation; Potentially
involved in apoptosis
93.
How G-protein-coupled receptors work (1)
extracellular space
cytosol
heterotrimeric
G-protein
‘7TM’ - receptor
GDP
GDP
N
GTP
Ligand
95. How G-protein-coupled receptors work (3)
ATP
inactive
inactive
active
cAMP
cAMP
Protein kinase A
Phosphorylation of multiple target proteins
GTP
active
Adenylate cyclase
96. Some G-proteins are inhibitory
-Adrenoceptor
2-Adrenoceptor
s
GTP
AC
active
AC
inactive
i
GTP
97. -Subunits of G proteins may have
regulatory activity, too
K+
Muscarinic (M2)
acetylcholine receptor
Kir
AC
inactive
i
GTP
98. G-proteins regulate diverse effector
systems
s
adenylate cyclase protein kinase AcAMP
i1
adenylate cyclase protein kinase AcAMP
q
phospholipase C
PIP2 IP3 + DAG protein kinase C
phosphorylation of
multiple proteins
Ca++
ER
t cGMP phosphodiesterase cGMP
99. Many transmitters have multiple GPCR with different
downstream signaling mechanisms
Norepinephrine, 1 IP3 + DAG
epinephrine2 cAMP
1,2 cAMP
Dopamine D2 - D4 cAMP
D1, D5 cAMP
Acetylcholine M1,,M4,M5IP3 + DAG
M2, M3 cAMP